UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005113 |
|---|---|
| Receipt number | R000006076 |
| Scientific Title | Evaluation of the clinical remission and its sustainment after discontinuation of infliximab in patients with rheumatoid arthritis who receive "programmed" treatment in randomized controlled trial |
| Date of disclosure of the study information | 2011/03/31 |
| Last modified on | 2019/03/25 09:10:42 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/02/21 09:20:07 | ||
| 2 | Update | 2011/04/02 09:03:11 | Recruitment status |
|
| 3 | Update | 2011/04/02 09:10:31 | Anticipated trial start date |
|
| 4 | Update | 2011/04/03 15:40:39 | Institutions |
|
| 5 | Update | 2011/04/04 09:49:24 | Institutions |
|
| 6 | Update | 2011/08/22 14:33:37 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
| 7 | Update | 2013/03/19 00:04:13 | Target sample size |
|
| 8 | Update | 2014/02/21 10:13:26 | Recruitment status |
|
| 9 | Update | 2014/10/06 15:16:23 | TEL Last name of contact person Last name of contact person TEL Name of person sending information Name of person sending information TEL |
|
| 10 | Update | 2018/02/27 09:50:54 | Name of primary person or sponsor Organization Organization Category of Funding Organization |
|
| 11 | Update | 2018/02/27 10:18:19 | UMIN ID1 |
|
| 12 | Update | 2018/02/27 11:58:41 | Date analysis concluded |
|
| 13 | Update | 2018/02/27 12:02:48 | Institutions |
|
| 14 | Update | 2019/03/25 09:10:42 | Recruitment status Date of IRB Last follow-up date Date analysis concluded |
